Supurna VedBrat - 27 Feb 2025 Form 4 Insider Report for Roadzen Inc. (RDZN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Mar 2025, 16:53:57 UTC
Prior SEC filing
03 Sep 2024
Next SEC filing
21 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Jean-Noel Gallardo, Attorney-in-fact

Key filing fact

Supurna VedBrat filed Form 4 for Roadzen Inc. (RDZN) on 03 Mar 2025.

Key facts

  • This page summarizes Supurna VedBrat's Form 4 filing for Roadzen Inc. (RDZN).
  • 2 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 03 Mar 2025, 16:53.

Change

  • Previous filing in this sequence was filed on 03 Sep 2024.
  • Current net transaction value: +$6,216.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RDZN transaction

Ordinary Shares

Purchase

Transaction value
$6,180
Shares
+6,000
Change %
+50%
Price
$1.03
Shares after
18,050
Date
27 Feb 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RDZN transaction Derivative

Warrants

Purchase

Transaction value
$36
Shares
+600
Change %
+10%
Price
$0.0600
Shares after
6,350
Date
27 Feb 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
600
Exercise price
$11.50
Footnotes
F2, F3
RDZN holding Derivative

Convertible Debentures

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
$500,000
Date
27 Feb 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
58,823
Exercise price
$8.50
RDZN holding Derivative

Warrants

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
100,000
Date
27 Feb 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
100,000
Exercise price
Footnotes
F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.00 to $1.09, inclusive. The reporting person undertakes to provide to Roadzen Inc., any security holder of Roadzen Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Footnote F2

The warrants to purchase Ordinary Shares of Roadzen Inc. (the "Public Warrants"), are exercisable for a whole number of Ordinary Shares at any time (subject to certain exceptions provided by the governing warrant agreement).

Footnote F3

The Public Warrants will expire on September 20, 2028, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.

Footnote F4

The exercise price of the warrants reported herein (the "Warrants") is equal to 80% of the lower of (i) the volume-weighted average price ("VWAP") of the ordinary shares of the Issuer, as reported on relevant market or exchange, over the 60 trading days subsequent to the first loan funding under the Notes (as defined below), (ii) the opening price of the Issuer's ordinary shares, as reported on the relevant market or exchange, in any public offering of straight equity securities of the Issuer occurring within six months after the issue date of the warrants and (iii) the VWAP of the Issuer's ordinary shares, as reported on the relevant market or exchange, over the 60 trading days immediately prior to the Vesting Date (as defined below).

Footnote F5

The Warrants are exercisable in full on March 28, 2025, or earlier under certain circumstances (as applicable, the "Vesting Date").

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .